文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

全球脊髓灰质炎根除进展——2022年1月至2023年12月

Progress Toward Poliomyelitis Eradication - Worldwide, January 2022-December 2023.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2024-05-16

1988年全球启动脊髓灰质炎根除目标,目前仅剩1型野生脊灰病毒(WPV1)在阿富汗和巴基斯坦地方性流行。本报告描述2022年1月至2023年12月全球脊灰免疫、监测和病毒流行病学情况,数据截至2024年4月10日。

要点

  • 2023年阿富汗和巴基斯坦共报告12例WPV1脊灰病例,2022年为22例。
  • 2023年循环疫苗衍生脊灰病毒(cVDPV)病例数从2022年的881例降至524例。
  • 2023年cVDPV疫情在32个国家发生,其中8国2022年未发生cVDPV疫情。

核心结论

  • 尽管2022年以来麻痹性脊灰病例减少,但2023年cVDPV病例和WPV1病例(在地方性传播国家)地理分布更广。
  • 需在WPV1地方性传播的国家和地区加强为持续漏种儿童接种疫苗、在高风险国家强化常规免疫规划并更有效应对cVDPV疫情,以进一步推进全球脊灰根除。

研究设计与样本

  • 本报告描述2022年1月至2023年12月全球脊灰免疫、监测活动和脊灰病毒流行病学,使用截至2024年4月10日的数据。

主要发现

  • 2023年阿富汗和巴基斯坦共报告12例WPV1脊灰病例,2022年为22例。
  • 通过污水样本系统检测(环境监测),在阿富汗和巴基斯坦的13个省检测到WPV1传播,2022年为7个省。
  • cVDPV病例数从2022年的881例降至2023年的524例。
  • 2023年cVDPV疫情(定义为有循环证据的cVDPV病例或至少两个阳性环境监测分离株)发生在32个国家,包括8个2022年未发生cVDPV疫情的国家。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In 1988, poliomyelitis (polio) was targeted for eradication. Global efforts have led to the eradication of two of the three wild poliovirus (WPV) serotypes (types 2 and 3), with only WPV type 1 (WPV1) remaining endemic, and only in Afghanistan and Pakistan. This report describes global polio immunization, surveillance activities, and poliovirus epidemiology during January 2022-December 2023, using data current as of April 10, 2024. In 2023, Afghanistan and Pakistan identified 12 total WPV1 polio cases, compared with 22 in 2022. WPV1 transmission was detected through systematic testing for poliovirus in sewage samples (environmental surveillance) in 13 provinces in Afghanistan and Pakistan, compared with seven provinces in 2022. The number of polio cases caused by circulating vaccine-derived polioviruses (cVDPVs; circulating vaccine virus strains that have reverted to neurovirulence) decreased from 881 in 2022 to 524 in 2023; cVDPV outbreaks (defined as either a cVDPV case with evidence of circulation or at least two positive environmental surveillance isolates) occurred in 32 countries in 2023, including eight that did not experience a cVDPV outbreak in 2022. Despite reductions in paralytic polio cases from 2022, cVDPV cases and WPV1 cases (in countries with endemic transmission) were more geographically widespread in 2023. Renewed efforts to vaccinate persistently missed children in countries and territories where WPV1 transmission is endemic, strengthen routine immunization programs in countries at high risk for poliovirus transmission, and provide more effective cVDPV outbreak responses are necessary to further progress toward global polio eradication.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Geiger K, Stehling-Ariza T, Bigouette JP, et al. Progress Toward Poliomyelitis Eradication - Worldwide, January 2022-December 2023. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38753550. doi:10.15585/mmwr.mm7319a4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。